arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ
$1.37 ▼ -0.12 (-8.05%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
65 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Bearish
auto_awesome

Analytical Summary

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth N/M
Op. Margin None
ROIC -23.9%
FCF / Share None
Trailing P/E
Price / Book 0.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

65-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0%
Net Income Profit after all expenses
$-1.41M
↑ +14.2%
Operating Margin Operating profit as % of sales
-314.9%
↑ +33.8%
FCF / Share Free cash flow per share
$-0.24
↓ -62905.7%
Long-Term Debt Long-term obligations
$342.45K
↓ -48.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
11
Cash Quality
64

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 65 quarters